Jane N. Winter

Northwestern University — United States

Medicine · Health Sciences

62h-index15.7kcitations556works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(340), Chronic Lymphocytic Leukemia Research(148), CAR-T cell therapy research(106), Viral-associated cancers and disorders(77), CNS Lymphoma Diagnosis and Treatment(60)

Publications556 total

Longitudinal echocardiographic monitoring and cardiovascular outcomes in adult survivors of childhood cancer
Cardio-Oncology·2025Open Access
Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium
Blood Advances·2025Open Access
Socioeconomic disadvantage, as measured by area deprivation index (ADI), impacts survival in patients with relapsed/refractory aggressive lymphoma treated with CART
Blood·2025Open Access
Real-world outcomes with bispecific antibody therapies for aggressive B-cell lymphomas in octogenarians
Blood·2025Open Access
Risk factors for CRS and NT with bispecific antibodies: Data from the American bispecifics and CART (ABC) consortium
Blood·2025Open Access
Impact of sequencing of CART vs bi-specific antibody on survival in relapsed/refractory large B-cell lymphoma: An analysis from the ABC consortium
Blood·2025Open Access
Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium
Blood Advances·2025· 1 citedOpen Access
Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy
Blood Advances·2025Open Access
Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART
Cancers·2025Open Access
Impact of autonomic dysfunction on function, toxicity, and survival in patients with lymphoma treated with CART.
Journal of Clinical Oncology·2025
Comparative analysis of survival outcomes in infused versus not-infused patients with aggressive B-cell lymphoma referred for CART.
Journal of Clinical Oncology·2025
Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408
Blood Neoplasia·2025· 1 citedOpen Access
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy
Blood Cancer Journal·2025· 9 citedOpen Access
Clinical Outcomes of Transformed Marginal Zone Lymphoma and Richter Transformation with CAR T-Cell Therapy: A US Multicenter Real-World Analysis
Transplantation and Cellular Therapy·2025
A Comparison of Survival in Younger Vs Older Patients Treated with CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CART) for Aggressive B-Cell Lymphoma
Transplantation and Cellular Therapy·2025
Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART
Transplantation and Cellular Therapy·2025
No Impact of Prophylactic Corticosteroid Use in Patients Receiving Axicabtagene Ciloleucel for Large B-Cell Lymphoma
Transplantation and Cellular Therapy·2025
Variance in development of early and late cardiotoxicities in patients with lymphoma and myeloma receiving CAR T-cell therapies
Leukemia & lymphoma/Leukemia and lymphoma·2025· 2 cited
Clinical Outcomes of Transformed Follicular Lymphoma with CAR T-Cell Therapy: A US Multicenter Real-World Analysis
Blood·2024· 3 cited
Extended Follow up and Immune Alterations in Patients with Classic Hodgkin Lymphoma (cHL) Treated with Frontline Single Agent Pembrolizumab Followed By AVD Chemotherapy
Blood·2024Open Access
page 1 of 28Next →

Frequent Co-authors

Leo I. Gordon(16), Eric D. Hsi(12), Miguel Á. Piris(12), Carlo Visco(11), Alexandar Tzankov(11), Govind Bhagat(11), J. Han van Krieken(11), Michael Møller(11), Ken H. Young(11), Zijun Y. Xu‐Monette(10), Karen Dybkær(10), Attilio Orazi(10), Maurilio Ponzoni(10), Andrés J.M. Ferreri(10), L. Jeffrey Medeiros(10), Kristy L. Richards(9), April Chiu(9), Andrew M. Evens(8), Santiago Montes‐Moreno(8), Youli Zu(8)